FreshLeaf Analytics, a Southern Cannabis Holdings (SCH) division, has released Australia's most comprehensive medicinal cannabis Patient, Product and Pricing Analysis.
The study was conducted in Q3 2019 and includes insights into the pricing and availability of legal medicinal cannabis products in the Australian marketplace including:
Number of products in market jumps 40% in 6 months
Patient growth continues at break-neck speed, up 1000% year on year
Overall spend declines as doctors go for cheaper products
Issues around vehicle driving and government subsidies remain
The report has been welcomed by the sector, with key players
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
